Physician
Loop Pediatrics, PA
Loop Pediatrics, PA was paid $14.19M by Medicaid between Jan 2018 and Dec 2024, across 58 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 35% of everything it billed.
33Billing provider infoLOOP PEDIATRICS, PA
KISSIMMEE, FL 34741
KISSIMMEE, FL 34741
33aNPI1205130788assigned 12/27/2010
33bProvider typePediatrics Physician
28Total paid$14.19M
24GClaims398,373
24DCodes billed58
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Florida
Rank by total paid#11 of 971
Median peer was paid$238K
This provider vs. median60×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 74 | $2K | |
| 2019 | 62,082 | $1.89M | |
| 2020 | 56,353 | $2.29M | |
| 2021 | 71,537 | $2.92M | |
| 2022 | 84,908 | $2.90M | |
| 2023 | 72,300 | $2.69M | |
| 2024incomplete | 51,119 | $1.51M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 35% | 61,956 | 54,699 | $4.96M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 14% | 16,011 | 15,703 | $2.00M |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 11% | 14,662 | 14,281 | $1.56M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 11% | 13,097 | 12,080 | $1.55M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 11% | 43,704 | 30,647 | $1.49M |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 7.1% | 8,774 | 8,596 | $1.00M |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.8% | 10,203 | 9,027 | $394K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1.2% | 12,587 | 11,597 | $170K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 15,679 | 15,195 | $138K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | <1% | 1,229 | 1,128 | $130K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 1,460 | 1,388 | $126K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 17,676 | 16,332 | $121K |
46 more codes
| 99383 | <1% | 791 | $99K | |
| 90670 | <1% | 7,508 | $80K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 17,529 | $74K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 734 | $66K |
| 99382 | <1% | 382 | $49K | |
| 99384 | <1% | 304 | $44K | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 4,385 | $24K |
| G0270 | Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes | <1% | 19,935 | $20K |
| 90651 | <1% | 3,318 | $10K | |
| 90677 | <1% | 1,274 | $10K | |
| 92551 | <1% | 27,946 | $9K | |
| 0071A | <1% | 362 | $9K | |
| 99381 | <1% | 65 | $9K | |
| 0072A | <1% | 241 | $7K | |
| 87807 | <1% | 1,249 | $6K | |
| 90633 | <1% | 5,051 | $5K | |
| 90716 | <1% | 4,528 | $4K | |
| 90647 | <1% | 8,957 | $4K | |
| 90680 | <1% | 5,702 | $3K | |
| 90620 | <1% | 501 | $3K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 471 | $2K |
| 99173 | <1% | 28,110 | $2K | |
| 90713 | <1% | 9,427 | $2K | |
| 90707 | <1% | 4,436 | $2K | |
| 99442 | <1% | 89 | $2K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 39 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 322 | $2K |
| 90700 | <1% | 11,858 | $1K | |
| 90734 | <1% | 1,897 | $963.36 | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,323 | $891.59 |
| 90619 | <1% | 665 | $864.00 | |
| 90744 | <1% | 4,351 | $678.41 | |
| 90686 | <1% | 3,166 | $577.45 | |
| 90621 | <1% | 1,160 | $557.78 | |
| 0001A | <1% | 28 | $500.00 | |
| 0124A | <1% | 14 | $451.83 | |
| 0002A | <1% | 13 | $360.00 | |
| 90685 | <1% | 426 | $25.00 | |
| 91307 | <1% | 711 | $2.53 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 13 | $1.80 |
| 91300 | <1% | 170 | $1.01 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 0% | 49 | $0.00 |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 0% | 195 | $0.00 |
| 90715 | 0% | 1,612 | $0.00 | |
| 90710 | 0% | 14 | $0.00 | |
| 91312 | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMEHRA, SANJAY (OWNER)